Baricitinib in the Treatment of COVID-19
Baricitinib is a novel Janus kinase (JAK) inhibitor which has recently been included in recommendations for treatment of COVID-19. This chapter is focused on discussing the evidence available regarding the safety and efficacy of use of baricitinib alone or in combination with other therapies for tre...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/83948 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Baricitinib in the Treatment of COVID-19
- Baricitinib en el tratamiento de la artritis reumatoide
- COVID-19: From Pathophysiology to Treatment
- COVID-19 and Cancer: Biological Interconnection and Treatment
- Neurological Effects of COVID-19 and Its Treatment/Management
- Cellular Therapy as Promising Choice of Treatment for COVID-19
- Inclusive Review on Existing Treatment and Management Modalities for COVID-19